PRTA

Prothena

• TipRanks·05/15 22:33

  Prothena Shareholders Reaffirm Board, Auditor and Pay Policies

• PUBT·05/15 20:39

  Prothena shareholders re-elect directors at annual meeting

• PUBT·05/14 22:23

  Prothena files Form 3 initial beneficial ownership statement for William P. Scully

• TipRanks·05/14 19:18

  Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright

• TipRanks·05/10 13:30

  Analysts Offer Insights on Healthcare Companies: Aardvark Therapeutics, Inc. (AARD), Prothena (PRTA) and Eli Lilly & Co (LLY)

• Simply Wall St·05/09 04:48

  Prothena (PRTA) Heavy US$244 Million Annual Loss Tests Bullish Profitability Narratives

• TipRanks·05/09 01:51

  Prothena (PRTA) Gets a Hold from RBC Capital

• TipRanks·05/08 18:46

  Analyst Reiterates Buy on Prothena, Maintaining $30 Price Target on CYTOPE and PRX012-TfR Platform Strength

• Dow Jones·05/08 15:25

  Prothena Is Maintained at Market Outperform by Citizens

• Benzinga·05/08 15:15

  Citizens Maintains Market Outperform on Prothena Corp, Raises Price Target to $20

• TipRanks·05/08 10:14

  Prothena price target raised to $20 from $19 at Citizens

• TipRanks·05/07 22:36

  Prothena reports Q1 EPS 60c vs ($1.12) last year

• TipRanks·05/07 22:35

  Prothena cuts FY26 net cash used view to $18M-$23M from $50M-$55M

• Reuters·05/07 21:18

  Prothena posts Q1 revenue surge fueled by $50 million Novo Nordisk milestone payment

• PUBT·05/07 21:05

  Prothena publishes corporate overview presentation on protein dysregulation disease pipeline